FIELD: biotechnology.
SUBSTANCE: group of inventions refers to biotechnology and immunology. Recombinant fusion protein from immunogenic epitopes of human herpes viruses 1–8 types for herpes immunization is characterized by amino acid sequence SEQ ID NO: 1. DNA coding protein with nucleotide sequence SEQ ID NO: 2. Plasmid DNA for immunising against herpes is a plasmid expression vector pcDNA3.1 containing said DNA.
EFFECT: group of inventions allows to develop humoral and cellular immune response to herpes viruses.
3 cl, 3 tbl, 7 ex, 3 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PRODUCING L-AMINO ACIDS USING CORYNEBACTERIA USING GLYCINE CLEAVAGE SYSTEM | 2015 |
|
RU2713298C2 |
| CHIMERIC PROTEINS BASED ON HUMAN UTROPHIN AND DYSTROPHIN AND USE THEREOF FOR TREATING DUCHENNE MUSCULAR DYSTROPHY | 2021 |
|
RU2767335C1 |
| MATERIALS AND METHODS USED FOR TREATMENT OF RESPIRATORY DISEASES IN DOGS | 2020 |
|
RU2811752C2 |
| UNIVERSAL ANTIBODY-MEDIATED BIOSENSOR | 2016 |
|
RU2746486C2 |
| IMMUNO-INDUCING AGENT | 2016 |
|
RU2744843C2 |
| NUCLEIC ACID CONSTRUCTIONS AND VECTORS FOR GENOTHERAPY FOR TREATING WILSON'S DISEASE AND OTHER CONDITIONS | 2015 |
|
RU2745567C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING AND/OR PREVENTING MALIGNANT TUMOUR | 2016 |
|
RU2714205C2 |
| INFLUENZA VIRUS CAPABLE OF INFECTING CANINES AND ITS USE | 2020 |
|
RU2802222C2 |
| METHOD OF CONTROL OF HEART RHYTHM AND REDUCTION OF INDIVIDUAL CARDIOMYOCYTES USING THERMOGENETICS | 2022 |
|
RU2802995C1 |
| COMPOSITIONS AND METHODS FOR BIOLOGICAL PRODUCTION OF LACTATE FROM C1-COMPOUNDS USING TRANSFORMANTS OF LACTATE DEHYDROGENASE | 2014 |
|
RU2710714C2 |
